Your heart's own muscle fibers may be sending the wrong signals that trigger atrial fibrillation.

Atrial fibrillation is a common irregular heart rhythm, but doctors still lack a deep understanding of what causes it. Standard treatments, like burning away heart tissue near the pulmonary veins to block rogue signals, do not always stop the condition or prevent blood clots. This often happens because of atrial cardiomyopathy, a disease that alters the heart's upper chambers structurally, electrically, and mechanically. The authors reviewed evidence showing that tiny motor units in heart muscle cells, called sarcomeres, may drive this damage. When atrial sarcomeres become altered, either through genetics or acquired disease, they can trigger harmful chemical signaling. This adverse signaling leads to scar tissue, inflammation, nerve and hormone activation, and dangerous rhythm disturbances. Fortunately, researchers have spotted control mechanisms unique to atrial sarcomeres that help regulate blood pressure and volume. Scientists are now testing small-molecule drugs that activate or inhibit these sarcomeres to treat the disease.

Why it matters

Atrial fibrillation affects millions and current treatments often fail because they target symptoms, not root causes. This review suggests that tiny structural changes inside heart muscle cells—the sarcomeres—might be a common source of the problem. If true, it opens the door to drugs that fix the muscle itself rather than just managing the irregular rhythm.

Questions answered